The present results indicated that glycometabolic dysfunction might be a key factor in tumorigenesis and metastasis, and ChSy-2/pl-CSA system might be promising biomarkers for the diagnosis and treatment of choriocarcinoma. The gene discussed is CHPF; the disease is choriocarcinoma.